Results 181 to 190 of about 211,280 (349)

Pharmacokinetic and Pharmacodynamic Interactions Between Anti‐Asthma Drugs and Medicinal Plants: A Comprehensive Review

Phytotherapy Research, EarlyView.
ABSTRACT Asthma affects 260–300 million people worldwide. About 20%–35% of patients use medicinal plants with their asthma medication, often without telling their clinicians. Disclosure rates are low; up to 42% of asthma outpatients use herbal products, with no records in their charts.
Emine Kocyigit, Aylin Bülbül, Betul Kocaadam‐Bozkurt, Osman Bozkurt, Duygu Ağagündüz, Raffaele Capasso   +5 more
wiley   +1 more source

Role of sodium tungstate as a potential antiplatelet agent

, 2015
Rebeca Fernández-Ruiz,1,2 Marc Pino,3 Begoña Hurtado,4 Pablo García de Frutos,4 Carolina Caballo,3 Ginés Escolar,3 Ramón Gomis,1,2,5 Maribel Diaz-Ricart3 1Diabetes and Obesity Research Laboratory, Institut d' ...
Escolar G, Gomis R, Diaz-Ricart M, Hurtado B, Pino M, García de Frutos P, Fernández-Ruiz R, Caballo C   +7 more
core  

Endocytosis‐independent cytosolic entry of messenger RNA via fluorous bilayer zippering attenuating Toll‐like receptor signaling and enables ischemic tissue salvage

Smart Molecules, EarlyView.
The present study establishes a paradigm shift in synthetic mRNA delivery through the convergence of three orthogonal chemistries—perfluoro‐acylation, bio‐orthogonal click cross‐linking, and disulfide reduction—within a single, modular polymer architecture. Abstract A fundamental constraint of conventional messenger RNA (mRNA) delivery systems is their
Yue Wang, Haitao Xie, Guoqing Xiang, Yanhua Li, Changgui Tong, Hongyan Cui, Qixian Chen, Haidong Li, Yan Zhao   +8 more
wiley   +1 more source

Indobufen-based dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and network meta-analysis. [PDF]

J Int Med Res
Gopinath A, Heo J, Fatima A, Yerrajonna A, George H, Mohd R, Turjman T, Azuwike UB, Bien-Aimé DPC, Lefevre JAS, Rech L, Asfaw MD, Ekumbal JR, Dalil L, Khawar MMH.   +14 more
europepmc   +1 more source

Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.

The Lancet, 2017
D. Sibbing, Dániel Aradi, C. Jacobshagen, L. Gross, D. Trenk, T. Geisler, M. Orban, M. Hadamitzky, B. Merkely, R. Kiss, A. Komócsi, C. Dézsi, L. Holdt, Stephan B. Felix, R. Parma, M. Kłopotowski, R. Schwinger, J. Rieber, K. Huber, F. Neumann, L. Koltowski, J. Mehilli, Z. Huczek, S. Massberg   +23 more
semanticscholar   +1 more source

Biomarkers to predict outcomes in diabetic foot ulcers

VIEW, EarlyView.
Studies attempting to predict the healing outcome of diabetic foot ulcers (DFUs) have investigated various biological materials and recovered molecules that may aid in discriminating wounds that will heal and those that will not heal. This graphical abstract captures the commonly studied classes of biomarkers in the context of DFUs.
Julie Okiro, Kellie Fortune, Eimear Daly, Luca McCann, Merhan Soltan, Seamus Sreenan, Fabio Quondamatteo   +6 more
wiley   +1 more source

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.

Journal of the American Medical Association (JAMA), 2016
R. Yeh, E. Secemsky, D. Kereiakes, Sharon-Lise T. Normand, A. Gershlick, David J Cohen, J. Spertus, P. Steg, D. Cutlip, M. Rinaldi, E. Camenzind, W. Wijns, Patricia Apruzzese, Yang Song, J. Massaro, L. Mauri   +15 more
semanticscholar   +1 more source

Antiplatelet Therapy

, 2013
Antiplatelet ...
Patrono, Carlo
core  

Long‐Term Outcomes of Omniflow II and BioIntegral Xenografts for Open Aortic Reconstruction in Predominantly Infected Settings: A Multicenter Cohort Study

World Journal of Surgery, EarlyView.
Evidence surrounding conduit selection for open in situ aortic reconstruction remains limited, particularly for xenograft use in infected settings. We evaluated long‐term outcomes after open aortic and aorto‐iliac reconstruction using BioIntegral No‐React bovine grafts and Omniflow II biosynthetic grafts in patients unsuitable for autologous vein ...
Tijmen W. Kraai, Eline I. Reinders Folmer, Barzi Gareb, David J. Liesker, Ben R. Saleem, Clark J. Zeebregts, Vascular Xenograft Research Group   +6 more
wiley   +1 more source

Rare delayed thromboembolic complication 18 days after Woven EndoBridge implantation: A case report. [PDF]

Surg Neurol Int
Miyama M, Kamatani K, Shirakawa M.
europepmc   +1 more source